Immunovant, Inc.
IMVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764013
In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q4 2025
Institutional positions in Immunovant, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 197
- +14 vs. Q3 2025
- Shares held
- 108.6M
- +13.8M (+14.5%) vs. Q3 2025
- Total value
- $2.76B
- +$1.23B (+80.5%) vs. Q3 2025
- New holders
- 40
- 75 more added
- Sold out
- 26
- 54 more reduced
3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 226 | $4.25B |
| Q1 2026 | 216 | $2.75B |
| Q4 2025 | 197 | $2.76B |
| Q3 2025 | 186 | $1.53B |
| Q2 2025 | 169 | $1.54B |
| Q1 2025 | 194 | $1.62B |
| Q4 2024 | 187 | $1.98B |
| Q3 2024 | 182 | $2.26B |
| Q2 2024 | 197 | $1.97B |
| Q1 2024 | 209 | $2.27B |
| Q4 2023 | 228 | $2.88B |
| Q3 2023 | 181 | $2.57B |
| Q2 2023 | 147 | $1.05B |
| Q1 2023 | 142 | $903.7M |
| Q4 2022 | 133 | $1.00B |
| Q3 2022 | 112 | $238.1M |
| Q2 2022 | 94 | $156.5M |
| Q1 2022 | 112 | $218.6M |
| Q4 2021 | 118 | $322.4M |
| Q3 2021 | 119 | $293.6M |
| Q2 2021 | 110 | $407.5M |
| Q1 2021 | 120 | $654.3M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Immunovant, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −256,743−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −122,100−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −115,750−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −92,500−100.0% | Sold out |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −72,965−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −56,700−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Voleon Capital Management LP | 0 | $0 | 0.00% | −39,035−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −35,128−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −34,900−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −31,950−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −19,134−100.0% | Sold out |
| Fieldview Capital Management, LLC | 0 | $0 | 0.00% | −17,577−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −17,281−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −15,119−100.0% | Sold out |
| Abc Arbitrage SA | 0 | $0 | 0.00% | −14,639−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −13,654−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −12,976−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −2,058−100.0% | Sold out |
| Halbert Hargrove Global Advisors, LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Cloud Capital Management, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |